RAF1 and neoplasm: However, concurrent inhibition of the RAF-MEK-ERK kinases using an intermittent treatment schedule of 3 days on-4 days off to limit toxicity and efficient inhibition of tumor growth in PDX (patient-derived xenograft) models [32].